| Case report: posterior reversible leukoencephalopathy syndrome (PRES) as a biologically predictable neurological association in severe COVID-19. First reported case from … T Wijeratne, C Wijeratne, L Karimi, C Sales, SG Crewther Frontiers in Neurology 11, 600544, 2021 | 20 | 2021 |
| Clinical utility of serial systemic immune inflammation indices (SSIIi) in the context of post covid-19 neurological syndrome (PCNS) T Wijeratne, C Wijeratne Journal of the Neurological Sciences 423, 117356, 2021 | 18 | 2021 |
| A narrative review on the non-pharmacologic interventions in post-stroke depression T Wijeratne, C Sales, C Wijeratne Psychology Research and Behavior Management, 1689-1706, 2022 | 16 | 2022 |
| Secondary headaches-red and green flags and their significance for diagnostics T Wijeratne, C Wijeratne, N Korajkic, S Bird, C Sales, F Riederer Eneurologicalsci, 100473, 2023 | 5 | 2023 |
| Systematic review of existing stroke guidelines: case for a change T Wijeratne, C Sales, C Wijeratne, L Karimi, M Jakovljevic BioMed Research International 2022 (1), 5514793, 2022 | 2 | 2022 |
| What we now know about Long Covid and our Brains? CW T Wijeratne, M Morriss, L Karimi Persuit 2023 (Web), Cover story, 2023 | | 2023 |
| Migraine and Inflammation: The Clinical Utility of Serial Systemic Immune Inflammatory Indices (SSIIi) during an Inpatient Setting T Wijeratne, C Wijeratne, L Karimi, V Apostolopolous, C Sales Preprints, 2022 | | 2022 |
| POST COVID-19 NEUROLOGICAL SYNDROME-CURRENT STATUS AND FUTURE PERSPECTIVE T Wijeratne, C Sales, C Wijeratne, L Guo, L Karimi Neuroepidemiology, 94-94, 2022 | | 2022 |
| Happiness: A Novel Outcome Measure in Stroke? T Wijeratne, C Sales, C Wijeratne, M Jakovljevic Therapeutics and Clinical Risk Management, 747-754, 2021 | | 2021 |
| Migraine Research Review Volume 1, Issue 1 TW Chanith Wijeratne | | 2020 |
Tissa Wijeratne OAM MD PhD FRACP...Director, Australian Institute of Migraine, Professor of Neurology, Rajarata University, Sri Lanka在 rmit.edu.au 的电子邮件经过验证
